| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ACATAvasimibeEflucimibe| 1 | 2003 | Pharmacology of the ACAT inhibitor avasimibe (CI-1011). | 
| + | - | nl | Cardiovasc Drug Rev 21(1):33-50 (2003) Llaverias G |
| 2 | 2008 | Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic? | 
| + | - | nl | Cardiovasc Ther 26(1):65-74 (2008) Lopez-Farre AJ |
| 3 | 2001 | Catalysis of ACAT may be completed within the plane of the membrane: a working hypothesis. | 
| + | - | nl | J Lipid Res 42(12):1933-8 (2001) |
| 4 | 1985 | Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. | 
| + | - | nl | J Lipid Res 26(6):647-71 (1985) |
| 5 | 2009 | Acyl-coenzyme A:cholesterol acyltransferases. | 
| + | - | nl | Am J Physiol Endocrinol Metab 297(1):E1-9 (2009) |
| 6 | 2005 | ACAT inhibition: bad for macrophages, good for smooth muscle cells? | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(1):7-9 (2005) Fazio S |